Skip to main content
OpenTrials

Clinical trial condition

Small Cell Lung Cancer

Explore clinical trials studying Small Cell Lung Cancer. Study availability and eligibility vary by location and protocol.

242 public trials 55 recruiting studies
Refine in advanced search Browse all conditions

Small Cell Lung Cancer trial results

Completed

Picoplatin as Second-Line Therapy for Patients With Small Cell Lung Cancer

NCT00116610

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Disease Attributes, +14 more
Locations
  • Genesis Cancer Center Hot Springs, Arkansas, United States
  • Study Site Los Angeles, California, United States
  • Comprehensive Cancer Center Palm Springs, California, United States
  • Eastern Connecticut Hematology/Oncology Norwich, Connecticut, United States
View all 55 locations
View Trial Details
Completed

Evaluation of the Overall Survival of Meclinertant Versus Placebo After a First Line Chemotherapy With Cisplatin + Etoposide

NCT00290953

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Lung Cancer, +14 more
Locations
  • Sanofi-Aventis Administrative Office Buenos Aires, Argentina
  • Sanofi-Aventis Administrative Office Macquarie Park, Australia
  • Sanofi-Aventis Administrative Office Diegem, Belgium
  • Sanofi-Aventis Administrative Office São Paulo, Brazil
View all 14 locations
View Trial Details
Active, Not Recruiting

A Study to Examine the Safety of Different Doses of BG-68501 Given to Participants With Advanced-Stage Tumors

NCT06257264

Conditions
Adnexal Diseases, Advanced Solid Tumor, Bladder Cancer, +55 more
Locations
  • Hoag Memorial Presbyterian Newport Beach, California, United States
  • Florida Cancer Specialists and Research Institute Lake Mary, Florida, United States
  • Washington University School of Medicine St Louis, Missouri, United States
  • Titan Health Partners Llc Dba Astera Cancer Care East Brunswick, New Jersey, United States
View all 24 locations
View Trial Details
Active, Not Recruiting

Study of JANX008 in Subjects With Advanced or Metastatic Solid Tumor Malignancies

NCT05783622

Conditions
Adenocarcinoma, Breast Diseases, Breast Neoplasms, +46 more
Locations
  • City of Hope Medical Center Duarte, California, United States
  • University of California, Davis Comprehensive Cancer Center Sacramento, California, United States
  • University of California San Diego Moores Cancer Center San Diego, California, United States
  • Winship Cancer Institute, Emory University Atlanta, Georgia, United States
View all 18 locations
View Trial Details
Active, Not Recruiting

Placebo-controlled, Study of Concurrent Chemoradiation Therapy With Pembrolizumab Followed by Pembrolizumab and Olaparib in Newly Diagnosed Treatment-Naïve Limited-Stage Small Cell Lung Cancer (LS-SCLC) (MK 7339-013/KEYLYNK-013)

NCT04624204

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Lung Diseases, +9 more
Locations
  • Ironwood Cancer & Research Centers ( Site 0007) Chandler, Arizona, United States
  • Loma Linda University Cancer Center ( Site 0011) Loma Linda, California, United States
  • Georgetown University ( Site 0017) Washington D.C., District of Columbia, United States
  • Moffitt Cancer Center ( Site 0137) Tampa, Florida, United States
View all 187 locations
View Trial Details
Active, Not Recruiting

Study of Tarlatamab in Combination With YL201 With or Without Anti-programmed Death Ligand 1 (PD-L1) in Participants With Extensive Stage (ES) Small Cell Lung Cancer (SCLC)

NCT06898957

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Lung Diseases, +8 more
Locations
  • City of Hope Orange County Lennar Foundation Cancer Center Irvine, California, United States
  • Yale New Haven Hospital New Haven, Connecticut, United States
  • Moffitt Cancer Center Tampa, Florida, United States
  • Dana Farber Cancer Institute Boston, Massachusetts, United States
View all 36 locations
View Trial Details

Related conditions